{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:41:36Z","timestamp":1784691696439,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T00:00:00Z","timestamp":1552348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005969","name":"Universit\u00e0 di Bologna","doi-asserted-by":"publisher","award":["RFO2015"],"award-info":[{"award-number":["RFO2015"]}],"id":[{"id":"10.13039\/501100005969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005969","name":"University of Bologna","doi-asserted-by":"crossref","award":["RFO2015"],"award-info":[{"award-number":["RFO2015"]}],"id":[{"id":"10.13039\/501100005969","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s11739-019-02070-y","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T04:19:13Z","timestamp":1552364353000},"page":"949-956","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Effects of allopurinol and febuxostat on cardiovascular mortality in elderly heart failure patients"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4367-3884","authenticated-orcid":false,"given":"Arrigo Francesco Giuseppe","family":"Cicero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio Roberto","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanari","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Degli Esposti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,12]]},"reference":[{"issue":"1","key":"2070_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/eurjhf\/hft132","volume":"16","author":"H Huang","year":"2014","unstructured":"Huang H, Huang B, Li Y, Huang Y, Li J, Yao H, Jing X, Chen J, Wang J (2014) Uric acid and risk of heart failure: a systematic review and meta-analysis. Eur J Heart Fail 16(1):15\u201324. \n                    https:\/\/doi.org\/10.1093\/eurjhf\/hft132","journal-title":"Eur J Heart Fail"},{"key":"2070_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.metabol.2018.02.007","volume":"83","author":"A Mantovani","year":"2018","unstructured":"Mantovani A, Targher G, Temporelli PL, Lucci D, Gonzini L, Nicolosi GL, Marchioli R, Tognoni G, Latini R, Cosmi F, Tavazzi L, Maggioni AP, Investigators GISSI-HF (2018) Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: a post hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial. Metabolism 83:205\u2013215. \n                    https:\/\/doi.org\/10.1016\/j.metabol.2018.02.007","journal-title":"Metabolism"},{"key":"2070_CR3","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1016\/j.jacc.2008.01.068","volume":"51","author":"JM Hare","year":"2008","unstructured":"Hare JM, Mangal B, Brown J, Fisher C Jr, Freudenberger R, Colucci WS, Mann DL, Liu P, Givertz MM, Schwarz RP, Investigators OPT-CHF (2008) Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. J Am Coll Cardiol 51:2301\u20132309. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2008.01.068","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"2070_CR4","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.114.014536","volume":"131","author":"MM Givertz","year":"2015","unstructured":"Givertz MM, Anstrom KJ, Redfield MM, Deswal A, Haddad H, Butler J, Tang WH, Dunlap ME, LeWinter MM, Mann DL, Felker GM, O\u2019Connor CM, Goldsmith SR, Ofili EO, Saltzberg MT, Margulies KB, Cappola TP, Konstam MA, Semigran MJ, McNulty SE, Lee KL, Shah MR, Hernandez AF, NHLBI Heart Failure Clinical Research Network (2015) Effects of xanthine oxidase inhibition in hyperuricemic heart failure patients: the xanthine oxidase inhibition for hyperuricemic heart failure patients (EXACT-HF) study. Circulation 131(20):1763\u20131771. \n                    https:\/\/doi.org\/10.1161\/circulationaha.114.014536","journal-title":"Circulation"},{"issue":"1","key":"2070_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40265-017-0839-5","volume":"78","author":"AF Cicero","year":"2018","unstructured":"Cicero AF, Pirro M, Watts GF, Mikhailidis DP, Banach M, Sahebkar A (2018) Effects of allopurinol on endothelial function: a systematic review and meta-analysis of randomized placebo-controlled trials. Drugs 78(1):99\u2013109. \n                    https:\/\/doi.org\/10.1007\/s40265-017-0839-5","journal-title":"Drugs"},{"key":"2070_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejim.2016.07.026","volume":"37","author":"AF Cicero","year":"2017","unstructured":"Cicero AF, Rosticci M, Fogacci F, Grandi E, D\u2019Addato S, Borghi C, Brisighella Heart Study Group (2017) Serum uric acid level is associated to poorly controlled blood pressure and arterial stiffness in hypertensive subjects: data from the Brisighella Heart Study. Eur J Intern Med 37:38\u201342. \n                    https:\/\/doi.org\/10.1016\/j.ejim.2016.07.026","journal-title":"Eur J Intern Med"},{"key":"2070_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/eci.12273","volume":"44","author":"C Borghi","year":"2014","unstructured":"Borghi C, Cosentino ER, Rinaldi ER, Cicero AF (2014) Uricemia and Ejection Fraction in elderly heart failure outpatients. Eur J Clin Invest 44:573\u2013578. \n                    https:\/\/doi.org\/10.1111\/eci.12273","journal-title":"Eur J Clin Invest"},{"issue":"7","key":"2070_CR8","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.hrthm.2014.04.003","volume":"11","author":"L Tamariz","year":"2014","unstructured":"Tamariz L, Hernandez F, Bush A, Palacio A, Hare JM (2014) Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm 11(7):1102\u20131108. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2014.04.003","journal-title":"Heart Rhythm"},{"issue":"1","key":"2070_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000488851","volume":"140","author":"M Nodera","year":"2018","unstructured":"Nodera M, Suzuki H, Matsumoto Y, Kamioka M, Kaneshiro T, Yoshihisa A, Ohira T, Takeishi Y (2018) Association between serum uric acid level and ventricular tachyarrhythmia in heart failure patients with implantable cardioverter-defibrillator. Cardiology 140(1):47\u201351. \n                    https:\/\/doi.org\/10.1159\/000488851","journal-title":"Cardiology"},{"key":"2070_CR10","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/eurheartj\/ehq473","volume":"32","author":"GS Filippatos","year":"2011","unstructured":"Filippatos GS, Ahmed MI, Gladden JD, Mujib M, Aban IB, Love TE, Sanders PW, Pitt B, Anker SD, Ahmed A (2011) Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data. Eur Heart J 32:712\u2013720. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehq473","journal-title":"Eur Heart J"},{"issue":"11","key":"2070_CR11","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.amjcard.2014.09.008","volume":"114","author":"M Vaduganathan","year":"2014","unstructured":"Vaduganathan M, Greene SJ, Ambrosy AP, Mentz RJ, Subacius HP, Chioncel O, Maggioni AP, Swedberg K, Zannad F, Konstam MA, Senni M, Givertz MM, Butler J, Gheorghiade M, EVEREST trial investigators (2014) Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with Tolvaptan trial). Am J Cardiol 114(11):1713\u20131721. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2014.09.008","journal-title":"Am J Cardiol"},{"key":"2070_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ijcard.2016.11.077","volume":"228","author":"Y Otaki","year":"2017","unstructured":"Otaki Y, Watanabe T, Kinoshita D, Yokoyama M, Takahashi T, Toshima T, Sugai T, Murase T, Nakamura T, Nishiyama S, Takahashi H, Arimoto T, Shishido T, Miyamoto T, Kubota I (2017) Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure. Int J Cardiol 228:151\u2013157. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2016.11.077","journal-title":"Int J Cardiol"},{"key":"2070_CR13","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1161\/HYPERTENSIONAHA.117.09081","volume":"69","author":"C Borghi","year":"2017","unstructured":"Borghi C, Cicero AF (2017) Serum uric acid and cardiometabolic disease. Another brick in the wall? Hypertension 69:1011\u20131013. \n                    https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.09081","journal-title":"Hypertension"},{"key":"2070_CR14","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1536\/ihj.16-480","volume":"57","author":"S Sugihara","year":"2016","unstructured":"Sugihara S, Yamamoto K, Hisatome I (2016) Can xanthine oxidase inhibitors improve cardiac function in patients with chronic heart failure? Int Heart J 57:661\u2013662. \n                    https:\/\/doi.org\/10.1536\/ihj.16-480","journal-title":"Int Heart J"},{"key":"2070_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/VHRM.S115080","volume":"13","author":"M Bove","year":"2016","unstructured":"Bove M, Cicero AF, Veronesi M, Borghi C (2016) An evidence-based review on urate lowering treatments: implications for optimal treatment of chronic hyperuricaemia. Vasc Health Risk Manag 13:23\u201328. \n                    https:\/\/doi.org\/10.2147\/VHRM.S115080","journal-title":"Vasc Health Risk Manag"},{"issue":"1","key":"2070_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11739-015-1310-9","volume":"11","author":"AF Cicero","year":"2016","unstructured":"Cicero AF, Morbini M, Urso R, Rosticci M, Parini A, Grandi E, D\u2019Addato S, Borghi C, Brisighella Heart Study Group (2016) Association between self-reported snoring and arterial stiffness: data from the Brisighella Heart Study. Intern Emerg Med 11(1):77\u201383. \n                    https:\/\/doi.org\/10.1007\/s11739-015-1310-9","journal-title":"Intern Emerg Med"},{"issue":"1","key":"2070_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11739-014-1098-z","volume":"10","author":"AF Cicero","year":"2015","unstructured":"Cicero AF, Desideri G, Grossi G, Urso R, Rosticci M, D\u2019Addato S, Borghi C, Brisighella Heart Study Group (2015) Serum uric acid and impaired cognitive function in a cohort of healthy young elderly: data from the Brisighella Study. Intern Emerg Med 10(1):25\u201331. \n                    https:\/\/doi.org\/10.1007\/s11739-014-1098-z","journal-title":"Intern Emerg Med"},{"issue":"1","key":"2070_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/eurjhf\/hft128","volume":"16","author":"MA Valente","year":"2014","unstructured":"Valente MA, Hillege HL, Navis G, Voors AA, Dunselman PH, van Veldhuisen DJ, Damman K (2014) The chronic kidney disease epidemiology collaboration equation outperforms the modification of diet in renal disease equation for estimating glomerular filtration rate in chronic systolic heart failure. Eur J Heart Fail 16(1):86\u201394. \n                    https:\/\/doi.org\/10.1093\/eurjhf\/hft128","journal-title":"Eur J Heart Fail"},{"key":"2070_CR19","first-page":"1091","volume":"16","author":"MD Cheitlin","year":"2003","unstructured":"Cheitlin MD, Armstrong WF, Aurigemma GP, ACC, AHA, ASE et al (2003) ACC\/AHA\/ASE 2003 guideline update for the clinical application of echocardiography: summary article. A report of the American College of Cardiology\/American Heart Association task force on practice guidelines (ACC\/AHA\/ASE committee to update the 1997 guidelines for the clinical application of echocardiography). J Am Soc Echocardiogr 16:1091\u20131110","journal-title":"J Am Soc Echocardiogr"},{"key":"2070_CR20","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB et al (2005) Chamber Quantification Writing Group; American Society of Echocardiography\u2019s Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440\u20131463","journal-title":"J Am Soc Echocardiogr"},{"key":"2070_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1365-2362.2009.02234.x","volume":"40","author":"I Simera","year":"2010","unstructured":"Simera I, Moher D, Hoey J, Schulz KF, Altman DG (2010) A catalogue of reporting guidelines for health research. Eur J Clin Invest 40:35\u201353","journal-title":"Eur J Clin Invest"},{"key":"2070_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-019-02024-4","author":"A Belfiore","year":"2019","unstructured":"Belfiore A, Palmieri VO, Di Gennaro C, Settimo E, De Sario MG, Lattanzio S, Fanelli M, Portincasa P (2019) Long-term management of chronic heart failure patients in internal medicine. Intern Emerg Med. \n                    https:\/\/doi.org\/10.1007\/s11739-019-02024-4\n                    \n                  \n                           (Epub ahead of print)","journal-title":"Intern Emerg Med"},{"key":"2070_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11906-017-0793-3","volume":"19","author":"M Bove","year":"2017","unstructured":"Bove M, Cicero AF, Borghi C (2017) The effect of xanthine oxidase inhibitors on blood pressure and renal function. Curr Hypertens Rep 19:95. \n                    https:\/\/doi.org\/10.1007\/s11906-017-0793-3","journal-title":"Curr Hypertens Rep"},{"key":"2070_CR24","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1161\/01.CIR.0000066420.36123.35","volume":"107","author":"JM Hare","year":"2003","unstructured":"Hare JM, Johnson RJ (2003) Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology. Circulation 107:1951\u20131953","journal-title":"Circulation"},{"key":"2070_CR25","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1161\/01.CIR.0000041431.57222.AF","volume":"106","author":"U Landmesser","year":"2002","unstructured":"Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C, Harrison DG, Hornig B, Drexler H (2002) Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 106:3073\u20133078","journal-title":"Circulation"},{"key":"2070_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1124\/pr.58.1.6","volume":"58","author":"P Pacher","year":"2006","unstructured":"Pacher P, Nivorozhkin A, Szab\u00f3 C (2006) Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev 58:87\u2013114","journal-title":"Pharmacol Rev"},{"key":"2070_CR27","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.mehy.2007.06.018","volume":"70","author":"X Duan","year":"2008","unstructured":"Duan X, Ling F (2008) Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure? Med Hypotheses 70:578\u2013581","journal-title":"Med Hypotheses"},{"key":"2070_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ijcard.2018.03.077","volume":"261","author":"AF Cicero","year":"2018","unstructured":"Cicero AF, Kuwabara M, Johnson R, Bove M, Fogacci F, Rosticci M, Giovannini M, D\u2019Addato S, Borghi C, Brisighella Heart Study group (2018) LDL-oxidation, serum uric acid, kidney function and pulse-wave velocity: data from the Brisighella Heart Study cohort. Int J Cardiol 261:204\u2013208. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2018.03.077","journal-title":"Int J Cardiol"},{"issue":"13","key":"2070_CR29","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","volume":"378","author":"WB White","year":"2018","unstructured":"White WB, Saag KG, Becker MA, Borer JS, Gorelick PB, Whelton A, Hunt B, Castillo M, Gunawardhana L, CARES Investigators (2018) Cardiovascular safety of febuxostat or allopurinol in patients with gout. N Engl J Med 378(13):1200\u20131210. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1710895","journal-title":"N Engl J Med"},{"key":"2070_CR30","first-page":"393","volume":"10","author":"J Foody","year":"2017","unstructured":"Foody J, Turpin RS, Tidwell BA, Lawrence D, Schulman KL (2017) Major cardiovascular events in patients with gout and associated cardiovascular disease or heart failure and chronic kidney disease initiating a xanthine oxidase inhibitor. Am Health Drug Benefits 10:393\u2013401","journal-title":"Am Health Drug Benefits"},{"key":"2070_CR31","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.2147\/NDT.S145812","volume":"13","author":"L Xue","year":"2017","unstructured":"Xue L, Liu Y, Xue H, Xue J, Sun K, Wu L, Hou P (2017) Low uric acid is a risk factor in mild cognitive impairment. Neuropsychiatr Dis Treat 13:2363\u20132367. \n                    https:\/\/doi.org\/10.2147\/NDT.S145812","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2070_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejim.2017.03.014","volume":"41","author":"R Molino-Lova","year":"2017","unstructured":"Molino-Lova R, Sofi F, Pasquini G, Vannetti F, Del Ry S, Vassalle C, Clerici M, Sorbi S, Macchi C (2017) Higher uric acid serum levels are associated with better muscle function in the oldest old: results from the Mugello Study. Eur J Intern Med 41:39\u201343. \n                    https:\/\/doi.org\/10.1016\/j.ejim.2017.03.014","journal-title":"Eur J Intern Med"},{"issue":"9","key":"2070_CR33","first-page":"1295","volume":"18","author":"G Desideri","year":"2014","unstructured":"Desideri G, Castaldo G, Lombardi A, Mussap M, Testa A, Pontremoli R, Punzi L, Borghi C (2014) Is it time to revise the normal range of serum uric acid levels? Eur Rev Med Pharmacol Sci. 18(9):1295\u20131306","journal-title":"Eur Rev Med Pharmacol Sci."},{"issue":"1","key":"2070_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12872-018-0757-9","volume":"18","author":"M Bredemeier","year":"2018","unstructured":"Bredemeier M, Lopes LM, Eisenreich MA, Hickmann S, Bongiorno GK, d\u2019Avila R, Morsch ALB, da Silva SF, Campos GGD (2018) Xanthine oxidase inhibitors for prevention of cardiovascular events: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovasc Disord 18(1):24. \n                    https:\/\/doi.org\/10.1186\/s12872-018-0757-9","journal-title":"BMC Cardiovasc Disord"},{"key":"2070_CR35","first-page":"j2376","volume":"357","author":"C Borghi","year":"2017","unstructured":"Borghi C, Cicero AF (2017) Uric acid: beyond the interpretation of serum levels. Brit Med J 357:j2376","journal-title":"Brit Med J"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-019-02070-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-019-02070-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-019-02070-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T20:08:31Z","timestamp":1583870911000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-019-02070-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,12]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["2070"],"URL":"https:\/\/doi.org\/10.1007\/s11739-019-02070-y","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,12]]},"assertion":[{"value":"13 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Prof. Claudio Borghi is scientific consultant for Menarini International, no one of the other authors have direct nor indirect conflict of interest in the publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was carried out in the setting of current clinical practice and has been carried out in agreement with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statements of human and animal rights"}},{"value":"The study was approved by the local ethical board and each subject signed an informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}